Agency / Source: GenScript Corporation

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

GenScript Launches Upgraded eStain® 2.0 Protein Staining System - In response to high demand and invaluable feedback from our customers, GenScript USA Incorporation has launched an upgraded eStain® 2.0 Protein Staining System - GenScript.com
GenScript Launches Upgraded eStain® 2.0 Protein Staining System

 

PRZOOM - /newswire/ - Piscataway, NJ, United States, 2012/08/03 - In response to high demand and invaluable feedback from our customers, GenScript USA Incorporation has launched an upgraded eStain® 2.0 Protein Staining System - GenScript.com. 1548:HK

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

With same key features as the previous eStain™ 2.0 System, the upgraded eStain® 2.0 System provides fast and convenient protein gel staining in 7 minutes or less.Empowered by a redesigned and significantly advanced graphite electrode, the new system provides increased reliability, reproducibility in quality protein gel staining. "We strive to satisfy our customers'needs with diligent and innovative R&D efforts. I am confident that, from now on, our customers will enjoy the process of protein gel staining much more than before. With our eStain® 2.0 System, users will spend less time waiting and will never miss the messy steps of liquid handling by traditional methods." said John Wang, VP of New Technology Division.

The upgraded eStain® 2.0 System is accompanied by the same accessory Staining Pads (R-250, cat#L02011 or G-250, cat#L02012) as before for gel staining. An advanced graphite electrode (cat# L02017) is developed for the upgraded eStain® 2.0 System. For customers who have purchased the previous eStain™ 2.0 System, a free replacement of the upgraded system will be provided. Please contact your local sales representative or email us at order[.]proteinsignal.com or order[.]genscript.com for more detailed information.

About GenScript

GenScript (genscript.com), the largest gene synthesis supplier in the USA, is an internationally recognized Contract Research Organization (CRO) specialized in biological research and early-phase drug discovery services. In 2011, more than 2300 journal articles referred GenScript's services and products - making GenScript the most frequently referred biology CRO in the world. Its service portfolio includes bio-reagent services, assay development & screening, lead optimization, and antibody drug development. The renowned one-stop bioreagent services include custom gene synthesis and molecular biology, custom protein expression and purification, custom peptide synthesis, antibody production, and custom cell line development. Its headquarters is in Piscataway, New Jersey, with subsidiaries in France, Japan, and China.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: GenScript Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


GenScript Launches Upgraded eStain® 2.0 Protein Staining System

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
GenScript |
Contact: Sally Wang - GenScript.com 
732-885-9188 sallyw[.]genscript.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GenScript Corporation securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From GenScript Corporation / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Press Releases:

Ipsen to Acquire Epizyme, Expanding its Portfolio in Oncology
ANI Pharmaceuticals Adopts Veeva Commercial Cloud to Better Support Rare Disease Patients
GenScript ProBio and ProteoNic BV Signed a Strategic Cooperation Based on High Expressing Vector System
Ipsen Receives Positive Opinion in Europe for Dysport® in the Management of Urinary Incontinence in Adults
DSM Acquires Brazil’s Leading Animal Nutrition Technology Company to Boost Precision Services Offering
DSM and the World Food Programme Partner to Improve Nutrition Around the World
European Commission Approves Cabometyx® as A Second-line Treatment for People Living with Radioactive Iodine-refractory Differentiated Thyroid Cancer
Shionogi and NEC Enter into Strategic Research Collaboration for Novel Hepatitis B Therapeutic Vaccine
Boehringer Ingelheim Selects Veeva Development Cloud Worldwide to Bring Innovative Therapies to Patients Faster
Ipsen Announces Investment in New State-of-the-art Electronic Autoinjector for Somatuline® Autogel® / Somatuline® Depot (lanreotide)

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Limelon Advertising, Co.

Visit  RightITnow, Inc.







 
  ©2022 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today